However, current technologies utilizing ultrasound (US) and computed tomography (CT) have enabled researchers to safely and accurately target almost any tumor mass in the body [114,115,116], providing opportunities to use them for LDD of PD-1/PD-L1 ICIs. This evidence concerns the gene CD274 and neoplasm.